Medicalgorithmics SA
WSE:MDG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medicalgorithmics SA
WSE:MDG
|
PL |
|
Art's Way Manufacturing Co Inc
NASDAQ:ARTW
|
US |
|
Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret AS
IST:BRISA.E
|
TR |
Balance Sheet
Balance Sheet Decomposition
Medicalgorithmics SA
Medicalgorithmics SA
Balance Sheet
Medicalgorithmics SA
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
7
|
59
|
38
|
24
|
20
|
48
|
33
|
60
|
11
|
16
|
12
|
26
|
26
|
6
|
|
| Cash |
1
|
1
|
2
|
1
|
5
|
18
|
23
|
45
|
11
|
16
|
11
|
26
|
6
|
6
|
|
| Cash Equivalents |
6
|
58
|
36
|
23
|
15
|
30
|
10
|
16
|
0
|
0
|
0
|
0
|
19
|
0
|
|
| Short-Term Investments |
0
|
3
|
6
|
0
|
15
|
12
|
4
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
1
|
11
|
7
|
28
|
21
|
20
|
23
|
22
|
23
|
21
|
8
|
7
|
|
| Accounts Receivables |
2
|
2
|
1
|
10
|
6
|
16
|
20
|
18
|
21
|
16
|
19
|
5
|
4
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
12
|
1
|
2
|
1
|
6
|
4
|
16
|
4
|
3
|
|
| Inventory |
0
|
1
|
2
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
4
|
2
|
3
|
2
|
3
|
2
|
2
|
0
|
0
|
0
|
|
| Total Current Assets |
9
|
64
|
47
|
43
|
55
|
90
|
61
|
89
|
36
|
41
|
37
|
56
|
43
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
22
|
17
|
15
|
32
|
24
|
27
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
22
|
17
|
15
|
32
|
24
|
27
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
5
|
10
|
16
|
25
|
33
|
44
|
8
|
10
|
11
|
|
| Intangible Assets |
2
|
3
|
5
|
9
|
11
|
144
|
119
|
126
|
124
|
117
|
50
|
63
|
72
|
78
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
93
|
77
|
84
|
85
|
84
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Long-Term Investments |
3
|
8
|
31
|
41
|
35
|
19
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
2
|
5
|
17
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
93
|
77
|
84
|
85
|
84
|
1
|
1
|
1
|
1
|
|
| Total Assets |
14
N/A
|
76
+459%
|
84
+11%
|
95
+14%
|
102
+8%
|
370
+262%
|
289
-22%
|
316
+9%
|
283
-10%
|
283
+0%
|
114
-60%
|
122
+7%
|
122
0%
|
106
-13%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
59
|
2
|
1
|
2
|
3
|
6
|
2
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
7
|
12
|
9
|
23
|
22
|
1
|
3
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
3
|
2
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
11
|
8
|
58
|
13
|
7
|
8
|
5
|
3
|
2
|
|
| Other Current Liabilities |
1
|
1
|
2
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
3
|
3
|
|
| Total Current Liabilities |
2
|
2
|
2
|
4
|
3
|
73
|
18
|
72
|
28
|
37
|
40
|
10
|
12
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
77
|
64
|
8
|
24
|
29
|
19
|
4
|
2
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
4
|
2
|
3
|
3
|
5
|
4
|
8
|
9
|
9
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
38
|
35
|
41
|
29
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
4
|
3
|
5
|
6
|
5
|
|
| Total Liabilities |
2
N/A
|
2
+13%
|
3
+44%
|
4
+58%
|
3
-25%
|
193
+6 167%
|
120
-38%
|
126
+5%
|
87
-31%
|
76
-13%
|
67
-12%
|
27
-59%
|
29
+6%
|
29
-1%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Retained Earnings |
12
|
73
|
81
|
90
|
99
|
165
|
183
|
197
|
201
|
213
|
43
|
94
|
94
|
78
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
9
|
20
|
7
|
5
|
6
|
4
|
1
|
2
|
2
|
|
| Total Equity |
12
N/A
|
74
+520%
|
81
+10%
|
91
+12%
|
99
+9%
|
177
+78%
|
169
-5%
|
190
+12%
|
196
+3%
|
207
+6%
|
47
-77%
|
95
+100%
|
93
-2%
|
77
-17%
|
|
| Total Liabilities & Equity |
14
N/A
|
76
+459%
|
84
+11%
|
95
+14%
|
102
+8%
|
370
+262%
|
289
-22%
|
316
+9%
|
283
-10%
|
283
+0%
|
114
-60%
|
122
+7%
|
122
0%
|
106
-13%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
10
|
10
|
10
|
|